西布曲明和托吡酯复方制剂对减肥的疗效:对巴西成年人的回顾性队列研究

Heloisa Harumi Yamamoto, Thiago Fraga Napoli, João Eduardo Nunes Salles
{"title":"西布曲明和托吡酯复方制剂对减肥的疗效:对巴西成年人的回顾性队列研究","authors":"Heloisa Harumi Yamamoto, Thiago Fraga Napoli, João Eduardo Nunes Salles","doi":"10.1101/2024.05.25.24307923","DOIUrl":null,"url":null,"abstract":"<strong>Introduction</strong> Obesity is a chronic, prevalent, multifactorial disease, stigmatized and linked to multiple long-term complications, which makes the treatment currently available below of the expectations from what is necessary to combat it. Because of this limitation, off-label medications for the treatment of obesity, such as topiramate, have been widely used, in association with on-label medications, such as sibutramine, in order to achieve more effective weight loss.","PeriodicalId":501419,"journal":{"name":"medRxiv - Endocrinology","volume":"58 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"EFFICACY OF SIBUTRAMINE AND TOPIRAMATE COMBINATION IN WEIGHT LOSS: RETROSPECTIVE COHORT STUDY ON BRAZILIAN ADULTS\",\"authors\":\"Heloisa Harumi Yamamoto, Thiago Fraga Napoli, João Eduardo Nunes Salles\",\"doi\":\"10.1101/2024.05.25.24307923\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Introduction</strong> Obesity is a chronic, prevalent, multifactorial disease, stigmatized and linked to multiple long-term complications, which makes the treatment currently available below of the expectations from what is necessary to combat it. Because of this limitation, off-label medications for the treatment of obesity, such as topiramate, have been widely used, in association with on-label medications, such as sibutramine, in order to achieve more effective weight loss.\",\"PeriodicalId\":501419,\"journal\":{\"name\":\"medRxiv - Endocrinology\",\"volume\":\"58 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.05.25.24307923\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.05.25.24307923","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

简介:肥胖症是一种慢性、多发、多因素疾病,被视为一种耻辱,并与多种长期并发症相关联,这使得目前可用的治疗方法低于防治肥胖症所需的期望值。由于这种局限性,治疗肥胖症的标签外药物(如托吡酯)与标签内药物(如西布曲明)一起被广泛使用,以达到更有效的减肥效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
EFFICACY OF SIBUTRAMINE AND TOPIRAMATE COMBINATION IN WEIGHT LOSS: RETROSPECTIVE COHORT STUDY ON BRAZILIAN ADULTS
Introduction Obesity is a chronic, prevalent, multifactorial disease, stigmatized and linked to multiple long-term complications, which makes the treatment currently available below of the expectations from what is necessary to combat it. Because of this limitation, off-label medications for the treatment of obesity, such as topiramate, have been widely used, in association with on-label medications, such as sibutramine, in order to achieve more effective weight loss.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信